India Advances Parkinson's Disease Treatment with New Drug and Indigenous Research:

Steps are being made in India to enhance the treatment of Parkinson’s disease. Patients in India are beginning to have more access to advanced care options due to the introduction of internationally accepted drug therapies and advancements in local research, as noted by the Times of India.

A major breakthrough is the availability of Apomorphine, which has been used extensively in Western countries. In India, the drug is now available through injectors and infusion pumps. This provides rapid relief from motor symptoms for patients who do not respond well to other oral medication.

EVER Neuro Pharma, based out of Germany, has partnered with Celera Pharma to market the drug to hospitals and clinics in India. The Drug’s Controller General of India has approved apomorphine for use. It can be supplied through pen-like injectors or a pump that constantly dispenses the medication.

Experts estimate that up to 40% of Indian Parkinson’s patients could benefit from this device-assisted approach. With limited options for advanced symptoms previously available, this new therapy is a substantial shift in care standards.

Promising Developments from Indian Researchers

As Indian scientists look into a Parkinson’s disease cure, the country’s drug accessibility has also improved. A compound which halted the disease’s progression in mice was found by a Danish team alongside scientists of Chandigarh’s Institute of Microbial Technology. Testing is still in very early stages, however the findings are being regarded as very optimistic.

Delhi University researchers, on the other hand, have also built a molecule that assists in maintaining the brain’s neuron centers producing dopamine. If clinical trials are successful, the disease may eventually harness and protect cells in the brain, slowing or even preventing its onset.

While these advancements in science may not be available for use for several years, the developments are a sign of blossoming research being done in India.

A Static Technique is Never Enough

An Indian expert mentions that there is a lot more work put into treating Parkinson’s other than robotic-assisted therapy. As taught by most neurologists, the ideal treatment involves:

Tailored treatment with drugs
Physical activity
Nutrition
Surgical procedures such as Deep Brain Stimulation (DBS) when required

Deep Brain Stimulation (DBS) enables control of movement by inserting electrodes into the brain, offering enhanced accuracy to specific location areas. The method can be expensive and high risk, but many have undergone surgery and regained the ability to live independently.

Speech therapy and physical therapy are of equal significance. These therapies can help with day-to-day functions such as balancing and speaking.

Looking Ahead: Hope and Progress

The use of apomorphine and other medical research initiatives is changing how India treats Parkinson’s. These advancements are promising not just in controlling symptoms, but there is hope for earlier detection and intervention, along with potential cures.